A randomised controlled trial and parallel process evaluation to determine whether CFHealthHub, an intervention to help CF patients build better treatment habits, offers any benefit over usual care to adults with CF

Not Applicable

Completed

• Conditions: Specialty: Respiratory disorders, Primary sub-specialty: Respiratory disorders; UKCRC code/ Disease: Congenital Disorders/ Congenital malformations of the respiratory system; Respiratory; Congenital Disorders/ Congenital malformations of the respiratory system

• Registration Number: ISRCTN55504164
• Lead Sponsor: Sheffield Teaching Hospitals NSH Foundation Trust

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34556552/ (added 08/11/2023) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665573/ (added 08/11/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-10-12
• Study Completion: 2019-12-30
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 608

Inclusion Criteria

1. Diagnosed with CF and with data within the CF registry
2. Aged 16 years and above
3. Willing and able to take inhaled mucolytics or antibiotics via a chipped nebuliser (e.g. eTrack)

Exclusion Criteria

1. Post-lung transplant
2. People on the active lung transplant list
3. Patients receiving palliative care, with palliative intent, for whom trial participation could be a burden
4. Participants who lack capacity to give informed consent
5. Participants using dry powder devices to take antibiotics or mucolytics

Study & Design

• Study Type: Interventional
• Study Design: Not specified